tvt news Haberler
NEWYou can now listen to Fox News articles! Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035. GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — are intended to treat type 2 diabetes and obesity. Recent studies, however, have …
Read More »Who should be taking weight-loss drugs? Doctors share best candidates
